We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
-4.77%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$1.61B
AUM Growth
-$151M
Cap. Flow
-$42.4M
Cap. Flow %
-2.62%
Top 10 Hldgs %
46.28%
Holding
103
New
28
Increased
9
Reduced
25
Closed
20

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$24.3M
2
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$22.3M
3
NBIX icon
Neurocrine Biosciences
NBIX
+$20.6M
4
BHVN icon
Biohaven
BHVN
+$20.2M
5
RSP icon
Invesco S&P 500 Equal Weight ETF
RSP
+$19.5M

Top Sells

Rank Stock Value
1
CYTK icon
Cytokinetics
CYTK
+$92.8M
2
MRK icon
Merck
MRK
+$61.6M
3
ACHC icon
Acadia Healthcare
ACHC
+$43.5M
4
ELV icon
Elevance Health
ELV
+$29.3M
5
AMGN icon
Amgen
AMGN
+$29.1M

Sector Composition

Rank Sector Weight
1 Healthcare 75.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HCA icon
26
HCA Healthcare
HCA
$87.7B
$20.8M 1.29%
69,441
-55,399
-44% -$19.4M
MOH icon
27
Molina Healthcare
MOH
$10.2B
$20.4M 1.26%
70,088
– –
RSP icon
28
Invesco S&P 500 Equal Weight ETF
RSP
$98.1B
$18.9M 1.17%
+108,041
New +$19.5M
UTHR icon
29
United Therapeutics
UTHR
$25.7B
$18.5M 1.15%
+52,500
New +$19.3M
CAH icon
30
Cardinal Health
CAH
$54.7B
$17.5M 1.09%
+148,173
New +$17.3M
BHVN icon
31
Biohaven
BHVN
$2.03B
$16.1M 1%
+431,916
New +$20.2M
XBI icon
32
PUT
State Street SPDR S&P Biotech ETF
XBI
$9.61B
$16.1M 1%
+179,100
New +$17.4M
SLNO
33
DELISTED
Soleno Therapeutics
SLNO
$13.8M 0.86%
+307,503
New +$15.9M
KWEB icon
34
CALL
KraneShares CSI China Internet ETF
KWEB
$5.69B
$12.7M 0.79%
+434,700
New +$13.9M
SRPT icon
35
Sarepta Therapeutics
SRPT
$1.65B
$12.2M 0.75%
100,172
+11,956
+14% +$1.47M
IWM icon
36
CALL
iShares Russell 2000 ETF
IWM
$81.5B
$12.1M 0.75%
+54,800
New +$12.5M
SYK icon
37
Stryker
SYK
$131B
$11.6M 0.72%
32,349
-34,665
-52% -$12.8M
VEEV icon
38
Veeva Systems
VEEV
$33.8B
$11.6M 0.72%
55,383
+36,124
+188% +$7.94M
OSCR icon
39
Oscar Health
OSCR
$9.27B
$11.6M 0.72%
860,821
– –
XLV icon
40
State Street Health Care Select Sector SPDR ETF
XLV
$41.8B
$11.5M 0.71%
+83,806
New +$12.3M
ERAS icon
41
Erasca
ERAS
$6.23B
$11M 0.68%
4,390,427
-486,484
-10% -$1.33M
TMO icon
42
Thermo Fisher Scientific
TMO
$215B
$10.9M 0.68%
21,040
-37,393
-64% -$20.6M
PRAX icon
43
Praxis Precision Medicines
PRAX
$8.51B
$9.2M 0.57%
119,509
-63,583
-35% -$4.6M
CNC icon
44
Centene
CNC
$31.1B
$8.75M 0.54%
+144,501
New +$9.01M
TEVA icon
45
Teva Pharmaceuticals
TEVA
$39.8B
$8.75M 0.54%
+397,024
New +$7.22M
BBIO icon
46
BridgeBio Pharma
BBIO
$15.7B
$7.96M 0.49%
+290,242
New +$7.5M
SPY icon
47
State Street SPDR S&P 500 ETF Trust
SPY
$807B
$7.28M 0.45%
+12,427
New +$7.32M
ASND icon
48
Ascendis Pharma A/S
ASND
$16.1B
$7.21M 0.45%
52,392
-38,374
-42% -$5.05M
CNTA
49
DELISTED
Centessa Pharmaceuticals
CNTA
$6.23M 0.39%
371,766
+102,608
+38% +$1.7M
CRBU icon
50
Caribou Biosciences
CRBU
$149M
$6.16M 0.38%
3,876,462
-430,209
-10% -$865K
1
2
3 4 5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return
YL
YCG LLC Austin, Texas $1.1B AUM 4.87% 1-Year Est. Return

PFM Health Sciences's Q4 2024 Portfolio in Review

As of Q4 2024, PFM Health Sciences held 103 positions worth $1.61B, down 8.6% from $1.76B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

PFM Health Sciences's Q4 2024 filing shows 28 new, 9 increased, 25 reduced and 20 closed positions. Its largest new stake was DexCom: 328,763 shares worth $25.6M. The largest sale was Cytokinetics, an estimated $92.8M.

By sector, the portfolio is most concentrated in Healthcare at 75% of assets, down from 96% a quarter earlier.

  • PFM Health Sciences's largest Q4 2024 buy was DexCom: 328,763 shares worth $25.6M.
  • PFM Health Sciences added most to Edwards Lifesciences in Q4 2024, an estimated $14.2M increase.
  • PFM Health Sciences's biggest Q4 2024 reduction was Intuitive Surgical, cutting an estimated $23M.
  • PFM Health Sciences fully exited Cytokinetics in Q4 2024, selling an estimated $92.8M.
  • PFM Health Sciences's ten largest holdings make up 46% of its $1.61B portfolio in Q4 2024.
  • PFM Health Sciences opened 28 new positions and closed 20 in Q4 2024.
  • PFM Health Sciences's portfolio value fell 8.6% quarter-over-quarter to $1.61B.

Based on PFM Health Sciences's 13F filing for Q4 2024, filed 14 Feb 2025.